From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.
Upcoming Events
Strategies for Improving Public Understanding of FDA-Regulated Products
Virtual Public Meeting
Mitigating Risks from Human Xylazine Exposure
Public Meeting: In-person and Virtual
Past Events
-
On September 12 and 13, the Foundation, in collaboration with the U.S. Food and Drug Administration, hosted a webinar to explore Good Clinical Practice Considerations for Trials with Pragmatic or Decentralized Features.
RAISE: Lessons Learned & Practical Applications for the Future
June 15, 2023
2-4 pm ET
RAISE: Reactions to Barriers, Facilitators, and Proposed Solutions
Thursday, June 1, 2023
2-3 PM ET
RAISE: Advanced Analytics: Interim Solutions When Race & Ethnicity are Missing
-
Considerations for Buprenorphine Initiation and Maintenance Care
Wednesday, May 10, 2023, 1 – 4:45 pm ET
RAISE: Considerations in the Measurement of Race and Ethnicity, Downstream Effects,
and Novel Methods to Address the Issues
RAISE: Missingness, Misclassification, and Measurement Bias in Race and Ethnicity
Thursday, April 20, 2023
2-3 PM ET
RAISE: Technical Challenges in the Transfer of Information
Thursday, April 6, 2023
2-3 PM ET